Conjugates (3-5) of Tn, sialyl Tn and HIV-1-derived peptide antigen with a N-tetradecanoyl L-serine-β-alanine-containing D-glucosamine derivative, structurally related to lipid A, as an immunoadjuvant for the development of totally synthetic vaccines against cancers or HIV were synthesized. The mitogenic activity of compounds 3, 4 and 5 was stronger than that of lipid A analogs (1, 2).
Tn 抗原、
唾液酸 Tn 抗原和 HIV-1 来源的肽抗原与一种结构类似于脂
多糖 A (lipid A) 的 N-
十四烷酰-
L-丝氨酸-
β-丙氨酸-含
D-葡糖胺衍
生物偶联物(3-5),被用作免疫佐剂,用于开发完全合成针对癌症或 HIV 的疫苗。化合物 3、4 和 5 的促有丝分裂活性均强于脂
多糖 A 类似物(1 和 2)。